The FDA has approved a new drug that could help all those that suffer from Alzheimer’s disease. This is the first new Alzheimer’s drug approved in almost 20 years and targets proteins called amyloids that are thought to play a part in cognitive decline. More studies on its effectiveness will continue to be done and the treatment is very expensive, coming in at over $50,000 a year. Robert Langreth, science and health reporter at Bloomberg News, joins us for more.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

<p>The FDA has approved a new drug that could help all those that suffer from Alzheimer’s disease. This is the first new Alzheimer’s drug approved in almost 20 years and targets proteins called amyloids that are thought to play a part in cognitive decline. More studies on its effectiveness will continue to be done and the treatment is very expensive, coming in at over $50,000 a year. Robert Langreth, science and health reporter at Bloomberg News, joins us for more.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.

Reopening America

New Alzheimer's Treatment Approved by the FDA, Not a Cure but Helps Slow Cognitive Decline

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/37fbaa0c-c2dc-43f4-b91b-ae390094d76b/transcript

Advertisement